SCHEMBL17201676

SCHEMBL17201676

COC(=O)c1ccc(-c2cc(C)nnc2C)s1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.42
LMNA P02545 2/20 0.42
PPARG P37231 1/20 0.42
NCOA2 Q15596 1/20 0.42
NCOA1 Q15788 1/20 0.42
NCOA3 Q9Y6Q9 1/20 0.42
IL2 P60568 2/20 0.41
HPGD P15428 6/20 0.40
ALDH1A1 P00352 5/20 0.40
CTSS P25774 1/20 0.39
CTSK P43235 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
ATM Q13315 1/20 0.38
KDM4E B2RXH2 2/20 0.37
POLB P06746 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CSNK2A2 P19784 1/20 0.37
KDR P35968 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17201694 0.87 HPGD (0.54) HPGDALDH1A1KDM4EPOLBNPC1
SCHEMBL17201636 0.86 HPGD (0.44) NPSR1LMNAPPARGNCOA2NCOA1
SCHEMBL17201602 0.80 NPSR1 (0.42) NPSR1LMNAPPARGNCOA2NCOA1
SCHEMBL17201539 0.76 KDM4E (0.45) NPSR1LMNAPPARGNCOA2NCOA1
SCHEMBL1235256 0.76 LMNA (0.60) NPSR1LMNAPPARGNCOA2NCOA1
SCHEMBL6498557 0.75 DAO (0.52) NPSR1LMNAPPARGNCOA2NCOA1
SCHEMBL17201606 0.74 HPGD (0.45) NPSR1LMNAPPARGNCOA2NCOA1
SCHEMBL7150192 0.73 HSD17B2 (0.54) NPSR1LMNAPPARGNCOA2NCOA1
SCHEMBL497921 0.72 ESR2 (0.63) NPSR1LMNAPPARGNCOA2NCOA1
SCHEMBL16896393 0.71 HDAC6 (0.43) NPSR1LMNAPPARGNCOA2NCOA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9725459-B2 3-oxo-tetrahydro-furo[3,2-B]pyrrol-4(5H)-yl) derivatives I GRUNENTHAL GMBH (DE) 2017-08-08 US disclosed
EP-3140309-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2017-03-15 EP disclosed
EP-3134414-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES II Grünenthal GmbH (DE) 2017-03-01 EP disclosed
WO-2015161928-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2015-10-29 WO disclosed
WO-2015161924-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES II Grünenthal GmbH (DE) 2015-10-29 WO disclosed
US-20150307507-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I Grünenthal GmbH (DE) 2015-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150307507-A1 3-OXO-TETRAHYDRO-FURO[3,2-B]PYRROL-4(5H)-YL) DERIVATIVES I CTSK, OPRK1, CAT NPSR1 583/4885LMNA 3359/4885PPARG 1648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.